Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region.
Anadkat MJ, Lacouture M, Friedman A, Horne ZD, Jung J, Kaffenberger B, Kalmadi S, Ovington L, Kotecha R, Abdullah HI, Grosso F. Anadkat MJ, et al. Among authors: kotecha r. Front Oncol. 2023 Jan 4;12:975473. doi: 10.3389/fonc.2022.975473. eCollection 2022. Front Oncol. 2023. PMID: 36703794 Free PMC article. Review.
Induction Chemotherapy and Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy for Inoperable Pancreas Cancer.
Chuong MD, Herrera R, Kaiser A, Rubens M, Romaguera T, Alvarez D, Kotecha R, Hall MD, McCulloch J, Ucar A, DeZarraga F, Aparo S, Joseph S, Asbun H, Jimenez R, Narayanan G, Gutierrez AN, Mittauer KE. Chuong MD, et al. Among authors: kotecha r. Front Oncol. 2022 Jun 23;12:888462. doi: 10.3389/fonc.2022.888462. eCollection 2022. Front Oncol. 2022. PMID: 35814383 Free PMC article.
Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy.
Hall MD, Mittauer KE, Herrera R, Von Werne K, Kotecha R, Kalman NS, McCulloch J, Alvarez D, McAllister NC, Doty DG, Rzepczynski AE, Deere W, Gutierrez AN, Chuong MD. Hall MD, et al. Among authors: kotecha r. Front Oncol. 2023 Jan 11;12:1037674. doi: 10.3389/fonc.2022.1037674. eCollection 2022. Front Oncol. 2023. PMID: 36713501 Free PMC article.
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study.
Leal T, Kotecha R, Ramlau R, Zhang L, Milanowski J, Cobo M, Roubec J, Petruzelka L, Havel L, Kalmadi S, Ward J, Andric Z, Berghmans T, Gerber DE, Kloecker G, Panikkar R, Aerts J, Delmonte A, Pless M, Greil R, Rolfo C, Akerley W, Eaton M, Iqbal M, Langer C; LUNAR Study Investigators. Leal T, et al. Among authors: kotecha r. Lancet Oncol. 2023 Sep;24(9):1002-1017. doi: 10.1016/S1470-2045(23)00344-3. Lancet Oncol. 2023. PMID: 37657460 Clinical Trial.
Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma.
Khagi S, Kotecha R, Gatson NTN, Jeyapalan S, Abdullah HI, Avgeropoulos NG, Batzianouli ET, Giladi M, Lustgarten L, Goldlust SA. Khagi S, et al. Among authors: kotecha r. Oncologist. 2024 Oct 14:oyae227. doi: 10.1093/oncolo/oyae227. Online ahead of print. Oncologist. 2024. PMID: 39401002 Free article.
357 results